Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Early hair loss may indicate risk of insulin resistance.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

The document concludes that adult mammalian skin contains multiple stem cell populations with specific markers, important for understanding skin regeneration and related conditions.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

The circadian clock influences the behavior and regeneration of stem cells in the body.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Quercetin may help with PCOS symptoms, but more research is needed.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.